These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12680801)

  • 1. Lasers for facial rejuvenation.
    Goldberg DJ
    Am J Clin Dermatol; 2003; 4(4):225-34. PubMed ID: 12680801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable pulse erbium:YAG laser skin resurfacing of perioral rhytides and side-by-side comparison with carbon dioxide laser.
    Newman JB; Lord JL; Ash K; McDaniel DH
    Lasers Surg Med; 2000; 26(2):208-14. PubMed ID: 10685094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation.
    El-Domyati M; Abd-El-Raheem T; Abdel-Wahab H; Medhat W; Hosam W; El-Fakahany H; Al Anwer M
    J Am Acad Dermatol; 2013 Jan; 68(1):103-12. PubMed ID: 23110966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet.
    Riggs K; Keller M; Humphreys TR
    Clin Dermatol; 2007; 25(5):462-73. PubMed ID: 17870524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple fractional erbium: yttrium-aluminum-garnet laser sessions for upper facial rejuvenation: clinical and histological implications and expectations.
    El-Domyati M; Abd-El-Raheem T; Medhat W; Abdel-Wahab H; Al Anwer M
    J Cosmet Dermatol; 2014 Mar; 13(1):30-7. PubMed ID: 24641603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating the Er:YAG laser.
    Zachary CB
    Lasers Surg Med; 2000; 26(2):223-6. PubMed ID: 10685096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lasers for facial rejuvenation: a review.
    Papadavid E; Katsambas A
    Int J Dermatol; 2003 Jun; 42(6):480-7. PubMed ID: 12786881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablative fractional lasers (CO(2) and Er:YAG): a randomized controlled double-blind split-face trial of the treatment of peri-orbital rhytides.
    Karsai S; Czarnecka A; Jünger M; Raulin C
    Lasers Surg Med; 2010 Feb; 42(2):160-7. PubMed ID: 20166156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifractional microablative laser combined with spacially modulated ablative (SMA) technology for facial skin rejuvenation.
    Hersant B; SidAhmed-Mezi M; Chossat A; Meningaud JP
    Lasers Surg Med; 2017 Jan; 49(1):78-83. PubMed ID: 27426249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic effect of a variable pulsed Er:YAG laser.
    Pozner JM; Goldberg DJ
    Dermatol Surg; 2000 Aug; 26(8):733-6. PubMed ID: 10940058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will nonablative rejuvenation replace ablative lasers? Facts and controversies.
    Lipozenčić J; Mokos ZB
    Clin Dermatol; 2013; 31(6):718-24. PubMed ID: 24160276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new infrared light device (1100-1800 nm) on facial lifting.
    Ahn JY; Han TY; Lee CK; Seo SJ; Hong CK
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):49-51. PubMed ID: 18201359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined fractional ablative and nonablative laser resurfacing treatment: a split-face comparative study.
    Cohen JL; Ross EV
    J Drugs Dermatol; 2013 Feb; 12(2):175-8. PubMed ID: 23377390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erbium:YAG cutaneous laser resurfacing.
    Alster TS; Lupton JR
    Dermatol Clin; 2001 Jul; 19(3):453-66. PubMed ID: 11599402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining confluent and fractionally ablative modalities of a novel 2790nm YSGG laser for facial resurfacing.
    Munavalli GS; Turley A; Silapunt S; Biesman B
    Lasers Surg Med; 2011 Apr; 43(4):273-82. PubMed ID: 21500221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo model of histologic changes after treatment with the superpulsed CO(2) laser, erbium:YAG laser, and blended lasers: a 4- to 6-month prospective histologic and clinical study.
    Greene D; Egbert BM; Utley DS; Koch RJ
    Lasers Surg Med; 2000; 27(4):362-72. PubMed ID: 11074514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing benefits and minimizing risk with CO2 laser resurfacing.
    Fitzpatrick RE
    Dermatol Clin; 2002 Jan; 20(1):77-86. PubMed ID: 11859596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial rhytides--subsurfacing or resurfacing? A review.
    Grema H; Greve B; Raulin C
    Lasers Surg Med; 2003; 32(5):405-12. PubMed ID: 12766965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Er:YAG laser resurfacing using combined ablation and coagulation modes.
    Trelles MA; Mordon S; Benítez V; Levy JL
    Dermatol Surg; 2001 Aug; 27(8):727-34. PubMed ID: 11493296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel explanation for the healing effect of the Er:YAG laser during skin rejuvenation.
    Lubart R; Friedmann H; Lavie R; Baruchin AM
    J Cosmet Laser Ther; 2010 Dec; 12(6):256-7. PubMed ID: 21142732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.